{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:52:02Z","timestamp":1784749922651,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"863 Plan Biological and Medical Technology","award":["2015AA020511"],"award-info":[{"award-number":["2015AA020511"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jns.2018.11.029","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:34:14Z","timestamp":1543379654000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis"],"prefix":"10.1016","volume":"396","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-0447","authenticated-orcid":false,"given":"Hongjuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanfen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0752-6956","authenticated-orcid":false,"given":"Honglu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2018.11.029_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/ICU.0b013e3283641b86","article-title":"Update in pediatric optic neuritis","volume":"24","author":"Collinge","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"7","key":"10.1016\/j.jns.2018.11.029_bb0010","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"Hoftberger","year":"2015","journal-title":"Mult. Scler."},{"issue":"4\u20135","key":"10.1016\/j.jns.2018.11.029_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.autrev.2014.01.009","article-title":"Diagnosis and classification of autoimmune optic neuropathy","volume":"13","author":"Petzold","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jns.2018.11.029_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"issue":"9451","key":"10.1016\/j.jns.2018.11.029_bb0025","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jns.2018.11.029_bb0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.jns.2018.11.029_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.jns.2018.11.029_bb0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","volume":"19","author":"Rostasy","year":"2013","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jns.2018.11.029_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ene.13315","article-title":"Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients","volume":"24","author":"Deschamps","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2018.11.029_bb0050","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jns.2018.11.029_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/0004-282x20170121","article-title":"MOG-IgG associated optic neuritis is not multiple sclerosis","volume":"75","author":"Costa","year":"2017","journal-title":"Arq. Neuropsiquiatr."},{"issue":"12","key":"10.1016\/j.jns.2018.11.029_bb0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2018.11.029_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.jns.2018.11.029_bb0070","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-016-8155-7","article-title":"Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages","volume":"263","author":"Zhou","year":"2016","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2018.11.029_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2018.11.029_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2018.11.029_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNO.0b013e318283c3ed","article-title":"Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system","volume":"33","author":"Storoni","year":"2013","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.jns.2018.11.029_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.11.029_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2016.09.007","article-title":"Different etiologies and prognoses of optic neuritis in demyelinating diseases","volume":"299","author":"Akaishi","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2018.11.029_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2018.11.029_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","author":"Zhao","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2018.11.029_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2018.11.029_bb0115","article-title":"Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children","author":"Ramanathan","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"issue":"11","key":"10.1016\/j.jns.2018.11.029_bb0120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2018.11.029_bb0125","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T08:52:43Z","timestamp":1566463963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18304829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"alternative-id":["S0022510X18304829"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.11.029","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}